Dacapobrain
Cambridge, US · Founded 2020 · 13 employees on LinkedIn · 1 known investors
Da Capo develops therapies aimed at halting the progression of neurodegenerative disease, using a target and drug discovery platform that combines data analytics, network biology, human iPS cell models, and chemistry and phenotypic screening. It focuses on recapitulating human neurodegenerative biology to identify disease drivers and move from target to lead compound.
Also known as Da Capo · DaCapo Brainscience
Founders & leadership
Dacapobrain was founded in 2020 by Matthew Peck, Lorenz Studer, and Vikram Khurana.
Investors · 1
Company profile
researched Aug 2026DaCapo Brainscience is a biotechnology company focused on developing therapies intended to halt the progression of neurodegenerative disease. The company operates a target and drug discovery platform built to recapitulate key aspects of human neurodegenerative biology.
The platform is described as combining four integrated systems: analytics for deriving biological insights from small and sparse data sets; network biology to map progression-associated signals and prioritize disease drivers; human induced pluripotent stem (iPS) cell models that recapitulate disease progression in vitro using complex systems including mature, aged cells; and chemistry and screening based on mechanism-linked phenotypic assays to move from target to lead compound.
▸Full profile — technology
Technology
The company's discovery platform integrates four components: data analytics designed to extract biological insight from small and sparse data sets, network biology used to map progression-associated signals and prioritize disease drivers, human iPS cell models that reproduce disease progression in vitro with complex systems containing mature and aged cells, and chemistry and phenotypic screening using mechanism-linked assays to progress from an identified target to a lead compound.
Compiled by commissioned research from 1 cited public sources — announcements, filings, and press listed under research sources below.
▸Research sources · 1
primary sources listed
- Dacapobraindacapobrain.com · web
1 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Dacapobrain do?
- DaCapo Brainscience is a drug discovery company developing therapies to halt the progression of neurodegenerative disease.
- Who founded Dacapobrain?
- Dacapobrain was founded by Matthew Peck, Lorenz Studer, Vikram Khurana in 2020.
- Who are Dacapobrain's investors?
- Dacapobrain's investors include Dns Capital.
- Where is Dacapobrain headquartered?
- Dacapobrain is headquartered in Cambridge, US.